These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 19002303)

  • 1. Red flags in scleroderma.
    Li Q; Sahhar J; Littlejohn G
    Aust Fam Physician; 2008 Oct; 37(10):831-4. PubMed ID: 19002303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M; Varga J
    Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How to recognize scleroderma].
    Francès C; Ayoub N; Barete S
    Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progressive systemic sclerosis].
    Schramm A; Maas D
    Med Klin; 1979 Nov; 74(46):1689-99. PubMed ID: 392285
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myositis disclosing systemic scleroderma].
    Leys D; Hatron PY; Parent M; Pasquier F; Krivosic I; Petit H
    Rev Neurol (Paris); 1984; 140(11):670-2. PubMed ID: 6505497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical spectrum of patients with anticentromere antibodies].
    Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T
    Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic sclerosis].
    Tamborrini G; Distler M; Distler O
    Med Monatsschr Pharm; 2008 May; 31(5):162-70; quiz 171-2. PubMed ID: 18552072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [When thinking to scleroderma?].
    Cogan E
    Rev Med Brux; 2007 Sep; 28(4):285-9. PubMed ID: 17958022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic scleroderma].
    Rommel A
    Sem Hop; 1984 Mar; 60(10):710-24. PubMed ID: 6322321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma.
    Akesson A; Wollheim FA
    Br J Rheumatol; 1989 Aug; 28(4):281-6. PubMed ID: 2787182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleroderma--clinical and pathological advances.
    Denton CP; Black CM
    Best Pract Res Clin Rheumatol; 2004 Jun; 18(3):271-90. PubMed ID: 15158741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Care of patients with scleroderma in the intensive care setting.
    Farber HW; Simms RW; Lafyatis R
    J Intensive Care Med; 2010 Sep; 25(5):247-58. PubMed ID: 20542965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progressive systemic sclerosis without cutaneous involvement].
    Pereira RM; Missi SM; Thomazini E; Yoshinari NH
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(3):144-7. PubMed ID: 3494294
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.
    Avouac J; Fransen J; Walker UA; Riccieri V; Smith V; Muller C; Miniati I; Tarner IH; Randone SB; Cutolo M; Allanore Y; Distler O; Valentini G; Czirjak L; Müller-Ladner U; Furst DE; Tyndall A; Matucci-Cerinic M;
    Ann Rheum Dis; 2011 Mar; 70(3):476-81. PubMed ID: 21081523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lung impairment in systemic sclerosis].
    Knoop H; Arinir U; Kreuter A; Walther JW; Schultze-Werninghaus G; Rohde G
    Pneumologie; 2009 Sep; 63(9):497-507. PubMed ID: 19708006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic complications of radial artery cannulation: an association with a calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia variant of scleroderma.
    Rose SH
    Anesthesiology; 1993 Mar; 78(3):587-9. PubMed ID: 8457059
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in the diagnosis and management of scleroderma-related vascular complications.
    Kerin K; Yost JH
    Compr Ther; 1998; 24(11-12):574-81. PubMed ID: 9847974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory features of Japanese patients with scleroderma and telangiectasia.
    Ashida R; Ihn H; Mimura Y; Jinnin M; Asano Y; Kubo M; Tamaki K
    Clin Exp Dermatol; 2009 Oct; 34(7):781-3. PubMed ID: 19508567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive systemic sclerosis (scleroderma).
    JAMA; 1973 Apr; 224(5 Suppl):711-6. PubMed ID: 4739736
    [No Abstract]   [Full Text] [Related]  

  • 20. [An update on systemic sclerosis].
    Kowal-Bielecka O
    Ann Acad Med Stetin; 2010; 56 Suppl 1():80-2. PubMed ID: 21365948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.